pd1-til
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Jan 1, 2017 (NCT03347097)
Timeline
Indications
Mechanism of action
- Programmed cell death 1 ligand 1Immunity, passive
CD274 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03944980 | Phase 3 | Jun 1, 2019 | Tianjin Medical University |
| NCT03950154 | Phase 3 | Jun 1, 2019 | Tianjin Medical University |
| NCT03347097 | Early Phase 1 (Phase 1) | Jan 1, 2017 | Fudan University, Shanghai Cell Therapy Research Institute |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tianjin Medical University | Academic/Hospital | 2 | 2 | 1 | 2019 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Shanghai Cell Therapy Research Institute | Academic/Hospital | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1